Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma
Year: 2017
Type: article
Abstract: The epigenetic reader BRD4 plays a vital role in transcriptional regulation, cellular growth control, and cell-cycle progression. Dysregulation of BRD4 function has been implicated in the pathogenesis of a wide range of cancers. However, how BRD4 is regulated to maintain its normal function in healthy cells and how alteration of this process leads to cancer remain poorly understood. In this study, we discovered that BRD4 is hyperphosphorylated in NUT midline carcinoma and identified CDK9 as a potential kinase mediating BRD4 hyperphosphorylation. Disruption of BRD4 hyperphosphorylation using both chemical and molecular inhibitors led to the repression of BRD4 downstream oncogenes and abrogation of cellular transformation. BRD4 hyperphosphorylation is also observed in other cancers displaying enhanced BRD4 oncogenic activity. Our study revealed a mechanism that may regulate BRD4 biological function through phosphorylation, which, when dysregulated, could lead to oncogenesis. Our finding points to strategies to target the aberrant BRD4 signaling specifically for cancer intervention.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1375395185, G1564983540, Mechanism of Brd4-mediated papillomavirus host interactions, Role of Histone and Histone-like Mutations in the Oncogenesis of Human Cancers, G432566759, Chromatin structure maintenance and cancer, G766257176, Penn Skin Biology and Diseases Resource-based Center, Merkel cell polyomavirus infection, host response, and viral oncogenic mechanism
OpenAlex ID: W2692842496
